ネイティブ・レジュード形成ペプチド連結のためのサイクルヒドロキシラミン:ウビキチンとティルゼパチドの合成
Jiling Han1, Kohtaro Hirao1, Toshiki Mikami1
1Laboratory for Organic Chemistry, Department of Chemistry and Applied Biosciences, ETH Zürich, Zürich 8093, Switzerland.
Journal of the American Chemical Society
|September 11, 2025
まとめ
新しいサイクルダイペプチド派生ヒドロキシラミンブロックは,α-ケトアシド-ヒドロキシラミン (KAHA) 化学を用いてネイティブペプチド結合を可能にします. チルゼパチドのような 治療用分子を含めた複雑なペプチドの合成を 促進します
科学分野:
- 化学生物学
- 合成化学
- ペプチド合成
背景:
- α-ケト酸-ヒドロキシラミン (KAHA) 結合は,ペプチド断片を結合するための化学選択的方法である.
- 現在のKAHA結合の制限は,一般的に使用される (S) - 5オキサプロリン構成要素による非原生ホモセリン残基の組み込みである.
研究 の 目的:
- 結合部位で正規のアミノ酸を生成するKAHA結合のための新しいヒドロキシラミンビルディングブロックを開発する.
- ネイティブペプチド配列と難しい合成標的へのKAHA結合の適用性を拡大する.
主な方法:
- サイクリックディペプチド由来ヒドロキシラミンの構成要素の開発.
- カノニカルアミノ酸を組み込むための改造されたKAHA結合条件の適用
- 選択的に保護されたユビキチン単体K48/K63の合成とティルゼパチドの全合成.
主要な成果:
- サイクルダイペプチド由来ヒドロキシラミンの合成に成功しました
- 非明らかな接点 (Leu-Ile,Lys-Ile) でKAHA結合が実証され,ネイティブアミノ酸が得られる.
- ユビキチン単体と複合ペプチドの治療用ティルゼパチドを合成するためにこの方法を適用した.
結論:
- ネイティブペプチド部位でのKAHA結合のための実用的な方法を確立した.
- 複合性および改変性ペプチドを合成するためのKAHA結合の有用性を拡大した.
- ユビキチン鎖の化学酵素合成とペプチド治療薬の総合成を可能にしました.
関連する概念動画
Preparation of Amides
3.9K
Amides are synthesized by treating carboxylic acids with amines in the presence of dehydrating agents like dicyclohexylcarbodiimide (DCC).
The DCC-promoted synthesis of amides begins with the protonation of DCC by carboxylic acid. The protonation makes it a better acceptor. Next, the addition of carboxylate to the protonated carbodiimide gives a reactive acylating agent.
Subsequently, the amine acts as a nucleophile that attacks the acylating agent to form a tetrahedral intermediate. In the...
The DCC-promoted synthesis of amides begins with the protonation of DCC by carboxylic acid. The protonation makes it a better acceptor. Next, the addition of carboxylate to the protonated carbodiimide gives a reactive acylating agent.
Subsequently, the amine acts as a nucleophile that attacks the acylating agent to form a tetrahedral intermediate. In the...
3.9K
Transducer Mechanism: Enzyme-Linked Receptors
3.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.9K
Preparation of 1° Amines: Hofmann and Curtius Rearrangement Overview
3.6K
In the presence of an aqueous base and a halogen, primary amides can lose the carbonyl (as carbon dioxide) and undergo rearrangement to form primary amines. This reaction, called the Hofmann rearrangement, can produce primary amines (aryl and alkyl) in high yields without contamination by secondary and tertiary amines.
3.6K
Preparation of Amines: Reductive Amination of Aldehydes and Ketones
3.7K
Carbonyl compounds and primary amines undergo reductive amination first to produce imines, followed by secondary amines in the same reaction mixture, using selective reducing agents like sodium cyanoborohydride or sodium triacetoxyborohydride. Reductive amination produces different degrees of substitution of amines depending on the starting amine substrate.
3.7K
Preparation of 1° Amines: Azide Synthesis
4.6K
Direct alkylation of ammonia produces polyalkylated amines, along with a quaternary ammonium salt. To exclusively prepare primary amines, the azide synthesis method can be used.
Azide ions act as good nucleophiles and react with unhindered alkyl halides to form alkyl azides. Alkyl azides do not participate in further nucleophilic substitution reactions, thereby eliminating the chances of polyalkylated products. Alkyl azides are reduced by hydride-based reducing agents, like lithium aluminum...
Azide ions act as good nucleophiles and react with unhindered alkyl halides to form alkyl azides. Alkyl azides do not participate in further nucleophilic substitution reactions, thereby eliminating the chances of polyalkylated products. Alkyl azides are reduced by hydride-based reducing agents, like lithium aluminum...
4.6K


